Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / SUPN - Supernus Pharmaceuticals EPS misses by $0.11 beats on revenue; reaffirms guidance

SUPN - Supernus Pharmaceuticals EPS misses by $0.11 beats on revenue; reaffirms guidance

Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals (SUPN): Q1 GAAP EPS of $0.11 misses by $0.11.Revenue of $130.9M (+37.8% Y/Y) beats by $3.71M.Full Year 2021 Financial Guidance: Total revenues of $550M - $580M vs. consensus of $569.47M; Operating earnings of $65M - $90M and Effective Tax Rate of 28% - 31%.Press Release

For further details see:

Supernus Pharmaceuticals EPS misses by $0.11, beats on revenue; reaffirms guidance
Stock Information
Company Name: Supernus Pharmaceuticals Inc.
Stock Symbol: SUPN
Market: NASDAQ
Website: supernus.com
Menu
SUPN SUPN Quote SUPN Short SUPN News SUPN Articles SUPN Message Board
Get SUPN Alerts

News, Short Squeeze, Breakout and More Instantly...